Compare Neurocrine Biosciences Inc (NBIX) vs Oklo Inc (OKLO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Neurocrine Biosciences Inc vs Oklo Inc — how do they compare? Neurocrine Biosciences Inc trades at $179 (market cap $17.40B), while Oklo Inc trades at $46.66 (market cap $7.22B). The key difference: Neurocrine Biosciences Inc is far larger — about 2.4× Oklo Inc's market cap, and Neurocrine Biosciences Inc is trading nearer its 52-week high, Oklo Inc nearer its low. Which is the better fit depends on your goals.
| NBIX | OKLO | |
|---|---|---|
Market Cap | $17.40B | $7.22B |
Sector | Health | Technology |
52-Week High | $180.55 | $174.14 |
52-Week Low | $123.10 | $41.11 |
Enterprise Value | $16.49B | $5.02B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →About Oklo Inc
Oklo Inc. is a company focused on developing and commercializing advanced fission power plants. The company specializes in micro-reactor technology, specifically the Aurora design, which uses advanced fuel to produce reliable, clean, and cost-competitive power. Oklo aims to provide scalable, on-site power solutions to various customers, including remote communities, industrial facilities, and government entities, positioning itself as an innovator in the next generation of nuclear energy.
Read more on OKLO →
